Walgreens reports strong Q2 results thanks to COVID-19 vaccine rollout

Walgreens Boots Alliance reported strong results for its second fiscal quarter and said money made from COVID-19 vaccinations should begin to offset pandemic-related losses, The Wall Street Journal reported March 31. 

The retail pharmacy giant said it has administered more than 8 million COVID-19 shots as of March 31, 4 million of those taking place in March. It expects to give a total of 26 million to 34 million shots by the end of its fiscal year on Aug. 31, the Journal reported. 

CMS announced early in March that it would increase the payment rate for vaccinations to $40 per dose, up from $28, which prompted Walgreens to boost its profit forecast. 

Walgreens reported $32.8 billion in sales, up almost 5 percent from the previous year, the Journal reported. Its profit also rose to $1.03 billion from $946 million last year. 

Read the full article here

More articles on pharmacy:
Shipments of J&J COVID-19 vaccines halted as FDA probes error that ruined 15M doses
FDA downplayed safety risks at Merck plant producing J&J COVID-19 vaccines, whistleblower says
White House knew 2 weeks ago that plant producing J&J vaccine had problems, Politico says


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars